NCT00526552已完成不适用
RAPID (Evaluating the Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes in Real World Practice)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 5,000
- 试验地点
- 1
研究概览
简要总结
To evaluate the efficacy of rosuvastatin in Korean dyslipidemia patients with diabetes
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hyperlipidemia patients who are prescribed with rosuvastatin 10mg, based on clinical grounds and fulfil the following criteria
- •Over 18 years of age
- •Diagnosed with DM based on fasting or post-load glucose data and/or clinical assessment by the clinician
排除标准
- •Patients already taking other hyperlipidemic agents
- •Patients who do not fulfil the indication criteria for statin therapy
- •Patients who do not have baseline and/or follow-up lipid data to verify the efficacy data
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )HypertensionDyslipidemiaNCT00526708AstraZeneca5,000
已完成
4 期
Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic SyndromeMetabolic SyndromeNCT00815659AstraZeneca97
已完成
不适用
Rosuvastatin on Diabetic Patients Treated With Glimepiride/MetforminDiabetes Mellitus, Type 2NCT03907423Rehab Werida70
已完成
不适用
Efficacy and Safety of a Generic Rosuvastatin in a Real-world SettingPrimary HypercholesterolemiaNCT03516955Hikma Pharmaceuticals LLC317
已完成
4 期
C-Reactive Protein (CRP) in Obese Diabetic WomenDiabetes Mellitus, Type 2NCT00262548AstraZeneca100